SCIENTIFIC HUB

Follow the evidence.

15.430 articles found

Source record

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis.

Rudå D, Jensen KG, Decara MS, Klauber DG, Fagerlund B, Møllegaard JR, Linnet K, Werge T, Correll CU, Fink-Jensen A, Jürgens G, Pagsberg AK.

J Clin Psychopharmacol · 2021-11-01

DOI: 10.1097/jcp.0000000000001490PMID: 34735099

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Frameless MLC-Based Radiosurgical Thalamotomies on the Modern Linear Accelerator Platform - Prospective Phase I/II Clinical Trial Results.

Thomas EM, Walker H, Middlebrooks EH, Fiveash JB, Nicholas A, Popple RA, Sung V, Stover N, Standaert DG, Guthrie BL, Bredel M.

Int J Radiat Oncol Biol Phys · 2021-11-01

DOI: 10.1016/j.ijrobp.2021.07.232PMID: 34700389

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline.

Arpin DJ, Mitchell T, Archer DB, Burciu RG, Chu WT, Gao H, Guttuso T, Hess CW, Lai S, Malaty IA, McFarland NR, Pasternak O, Price CC, Shukla AW, Wu SS, Okun MS, Vaillancourt DE.

Mov Disord · 2021-11-01

DOI: 10.1002/mds.28838PMID: 34724257

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Comparative Efficacy and Safety of Dopamine Agonists in Advanced Parkinson's Disease With Motor Fluctuations: A Systematic Review and Network Meta-Analysis of Double-Blind Randomized Controlled Trials.

Ruan X, Lin F, Wu D, Chen L, Weng H, Yu J, Wang Y, Chen Y, Chen X, Ye Q, Meng F, Cai G.

Front Neurosci · 2021-10-29

DOI: 10.3389/fnins.2021.728083PMID: 34776841

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease.

Neumann S, Taylor J, Bamford A, Metcalfe C, Gaunt DM, Whone A, Steeds D, Emmett SR, Hollingworth W, Ben-Shlomo Y, Henderson EJ.

BMC Neurol · 2021-10-29

DOI: 10.1186/s12883-021-02430-2PMID: 34715821

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Mechanistic Insight from Preclinical Models of Parkinson's Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy.

Delgado-Minjares KM, Martinez-Fong D, Martínez-Dávila IA, Bañuelos C, Gutierrez-Castillo ME, Blanco-Alvarez VM, Cardenas-Aguayo MD, Luna-Muñoz J, Pacheco-Herrero M, Soto-Rojas LO.

Int J Mol Sci · 2021-10-28

DOI: 10.3390/ijms222111702PMID: 34769132

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.